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Abstract 
 
The three title compounds show extensive hydrogen bonding networks in the solid state. The 
structure of diphenyl-2-isopropylimidazol-4(5)yl phosphane oxide (3) is dominated by N-H...OP 
hydrogen bonds, whereas in bis(2-isopropylimidazol-4(5)-yl)phenyl- (2) and tris(2-
isopropylimidazol-4(5)yl)phosphane oxide (1) both, N-H...N and N-H...OP hydrogen bonds 
determine the solid-state structures. Compound 1 crystallises in the monoclinic space group Cc with 
cell parameters a = 19.5447(6) Å, b = 10.45764(16) Å, c = 10.8549(3) Å and β = 121.418(4)°; 2 in 
the orthorhombic space group Pna21, with a = 11.5997(3) Å, b = 9.5836(2) Å, c = 16.1860(4) Å and 
3 in the orthorhombic space group Pca21, with a = 10.8430(2) Å, b = 10.9277(2) Å and c = 
27.7088(6) Å. 
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Introduction 
 
Tris(azolyl)phosphanes show a plethora of interesting properties as ligands in coordination 
chemistry. Most notably, they can adopt different coordination modes as e.g. N,N,N-, N,P- or P-
ligands as well as bridging two or more metal atoms. Tris(imidazolyl)phosphane complexes, 
usually bearing imidazol-2-yl moieties, have been used to mimic the active site of carbonic 
anhydrase and as water soluble ligands for gold based anti-tumour drugs.[1-8]  
We are especially interested in the coordination chemistry of the not so common imidazolyl 
phosphane regioisomers where the phosphorous atom is bound to the heteroaromatic ring via the 4- 
or 5-position. Although a number of metal complexes of these ligands have already been reported, 
only a few structures of ligands or their oxidation products were determined so far.[9-11]  
  
Here, we report on the solid state structure of the series of imidazol-4(5)yl phosphane oxide which, 
due to their P=O and N-H functionalities, show distinct hydrogen bonding in the solid state. 
 
 
Experimental 
 
Crystallography 
 
Crystallographic data were collected at 183(2) K on an Oxford Diffraction Xcalibur system with a 
Ruby detector using Mo Kα radiation (λ = 0.7107 Å) that was graphite-monochromated. Suitable 
crystals were covered with oil (Infineum V8512, formerly known as Paratone N), mounted on top 
of a glass fibre and immediately transferred to the diffractometer. The program suite CrysAlisPro 
was used for data collection, semi-empirical absorption correction and data reduction.[12] Structures 
were solved with direct methods using SIR97[13] and were refined by full-matrix least-squares 
methods on F2 with SHELXL-97.[14] The structures were checked for higher symmetry with help of 
the program Platon.[15] Crystallographic data for the structural analysis has been deposited with the 
Cambridge Crystallographic Data Centre, CCDC 769495 - 769497 for compounds 1-3. Copies of 
this information can be obtained free of charge from The Director, CCDC, 12 Union Road, 
Cambridge, CB2 1EZ, UK (fax: +44-1223-336033; e-mail: deposit@ccdc.cam.ac.uk or 
http://www.ccdc.cam.ac.uk). 
 
General Instrumentation 
 
All preparations were carried out in Schlenk tubes under an atmosphere of dry nitrogen using 
anhydrous solvents purified according to standard procedures. All chemicals were used as 
purchased. 1H and 31P NMR spectra were recorded on a Bruker DRX 200 spectrometer. The 1H and 
13C NMR spectra were calibrated against the residual proton signals and the carbon signals of the 
solvents as internal references ([D1]chloroform: δH = 7.24 ppm and δC = 77.0 ppm; [D4]methanol): 
δH = 5.84 ppm and δC = 49.1 ppm) while the 31P{1H} NMR spectra were referenced to external 85 
% H3PO4. Infrared spectra were recorded with a Bruker IFS 66 FT-IR spectrometer. Time-of-flight 
mass spectra were recorded on a Bruker Ultraflex TOF, ESI mass spectra on an ion-trap mass 
spectrometer Finnigan LCQ Deca and EI mass spectra on a GC/MS-system Thermo Finnigan Trace 
DSQ. 
 
Tris(2-isopropylimidazol-4(5)-yl)phosphane oxide (1) 
  
 
The compound 1 was prepared as previously described[1] and crystallised upon slow evaporation of 
a ethanolic solution to yield colourless needles. 
 
Bis(2-isopropylimidazol-4(5)-yl)phenyl phosphane oxide (2) 
 
To a solution of 1-diethoxymethyl-2-isopropylimidazole (10.6 g, 50.0 mmol) in 300 mL of diethyl 
ether 33 mL (53 mmol) of 1.6 M n-butyl lithium in hexane were added at –78 °C. The solution was 
stirred at – 78 °C for 30 min and additionally for 30 min at room temperature. After cooling to – 78 
°C PhPCl2 (3.39 mL, 25 mmol) of in 10 mL diethyl ether were added. The white suspension was 
stirred over night at room temperature, 75 mL of conc. NH4OH were added the organic layer 
separated, washed with water and dried over MgSO4. After removal of the solvent the oily residue 
was re-dissolved in 100 mL of acetone/water 10:1 and heated to reflux for 12 h. The resulting white 
precipitated was collected and recrystallized from methanol/acetone. 1H-NMR (200MHz, CDCl3): δ 
= 1,39 (d, 3JHH = 7 Hz, 12H), 3,12 (sept., 3JHH = 7 Hz, 2H), 7,24 (m, 5 H), 7,43 (d, JPH = 0,8 Hz). 
31P{1H}-NMR (81 MHz, CDCl3): δ = -63 (s). EI MS (70 eV, 240 °C): m/z (%) = 326 (100) [M]+, 
249 (18) [M-Ph]+, 217 (61) [M-imiPr]+. C18H23N4P (326.38): calc. C 66.2 H 7.1 N 17.2, found C 
65.6 H 7.1 N 17.1. A solution of the phosphane in ethanol is treated with H2O2 and stirred over 
night at ambient temperature. The solvent is removed in vacuo and the residue crystallised from 
ethanol/water. 1H-NMR (200MHz, [D4]methanol): δ = 1,37 (d, 3JHH = 7 Hz, 12 H), 3,17 (sept., 3JHH 
= 7 Hz, 1 H), 7,37 (s, 2 H), 7,74 (m, 5 H). 31P{1H}-NMR (81 MHz, [D4]methanol): δ = 12 (s). EI 
MS (70 eV, 290 °C): m/z (%) = 342 (100) [M]+, 327 (99) [M-O]+, 233 (49) [M-imiPr]+, 217 (72) [M-
O-imiPr]+. C18H23N4OP·2H2O (378.41): calc. C 57.1 H 7.2 N 14.8, found C 57.1 H 6.6 N 14.8. 
 
Diphenyl-2-isopropylimidazol-4(5)-yl phosphane oxide (3) 
 
Diphenyl-2-isopropylimidazol-4(5)-yl phosphane (4-MIPiPr) was prepared as previously reported.[3] 
For the oxidation of 4-MIPiPr to 4-MIPOiPr (3) diphenylimidazol-4(5)-yl phosphane was dissolved 
in ethanol and hydrogen peroxide was added until no more signal of the phosphane was observed in 
31P{1H} NMR. The mixture was stirred over-night, the solvent removed in vacuo, the resulting 
solid washed with acetone and diethyl ether and dried in vacuo. The solid thus obtained was 
dissolved in a minimum amount of methanol and crystallized by slow diffusion of diethyl ether into 
this solution. 1H NMR (200 MHz, [D4]methanol): δ = 1.35 (d, 6H, JHH = 7 Hz, CH(CH3)2), 3.16 
(sept, 1H, JHH = 7 Hz, CH(CH3)2), 7.32 (s, br, 1H, Him), 7.5 – 7.9 (m, 10 H, Ph) . 31P{1H} NMR (81 
  
MHz, [D4]methanol): δ = 24. EI MS (70 eV, 220 °C): m/z (%) = 310 (100) [M]+, 295 (84) [M-Me]+, 
233 (17) [M-Ph]+. C18H19N2OP (310.34): calc. C 69.7 H 6.2 N 9.0, found C 69.3 H 6.0 N 8.9. 
 
 
 
Results and Discussion 
 
The three phosphane oxides 1 - 3 (Fig. 1) are easily obtained by oxidising the corresponding 
phosphanes using hydrogen peroxide. Selected bond lengths and angles are summarised in Table 1. 
 
 
Fig. 1 Imidazoly-4(5)-yl phosphane oxides used in this study. 
 
Table 1 Selected bond lengths (Å) and angles (°) of 1 - 3. 
Compound 1 2 3 
d(P-O) 1.5014(10) 1.4957(10) 1.4956(13) 
d(P-C) 1.7694(15) 1.7793(12) 1.7693(19) 
 1.7706(13) 1.7792(13) 1.802(2) 
 1.7765(13) 1.8001(12) 1.802(2) 
<(C-P-C) 104.40(6) 106.34(6) 105.74(9) 
 107.52(6) 109.63(6) 106.70(9) 
 106.83(6) 103.81(6) 107.95(9) 
 
The P=O bond lengths in compounds 1 - 3 is significantly longer than the P=O bond length found in 
triphenylphosphane oxide (1.479(2) Å)[16], even when taken in account, that the P=O bond is 
elongated when involved in hydrogen bonding.[17, 18] 
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Fig. 2 View of the molecular structure of 1, showing 50 % probability ellipsoids (non acidic H-
atoms are omitted for clarity). The isopropyl group consisting of C16, C17, C18 shows a two fold 
disorder, only one conformer is shown. 
 
 
Fig. 3 View of the molecular structure of 2, showing 50 % probability ellipsoids (non acidic H-
atoms are omitted for clarity). 
 
 
  
 
Fig. 4 View of the molecular structure of 3, showing 50 % probability ellipsoids (non acidic H-
atoms and second molecule are omitted for clarity). 
 
Compound 1 crystallises in the monoclinic space group Cc whereas 2 and 3 crystallise in the 
orthorhombic space groups Pna21 and Pca21, with one and two molecules in the asymmetric unit 
respectively. In all three compounds the aromatic substituents exhibit a comparable propeller 
arrangement as found for the phenyl substituents in PPh3.[19,20] The conformation of the 2-
isopropylimidazolyl substituent in 3 resembles the one found in the Au(I)chlorido complex of this 
ligand.[3] In non of these compounds interactions between the aryl substituents similar to the 
sextuple phenyl embrace (SPE)[21] commonly found in crystal structures containing PPh3 are found, 
here hydrogen bonds are the more dominant intermolecular forces. 
 
In the solid state structures of compounds 1 to 3 hydrogen bonding networks are found. Columns of 
3 are orientated pair-wise parallel and anti-parallel to the a axis (Fig. 5).  The graph set 
description[22] of NH...OP hydrogen bonding is C(6). The rungs of these zick-zack ladder-like 
columns are formed by the imidazolyl substituents and the stiles by the phenyl and isopropyl 
groups. 
 
  
 
Fig. 5 Columnar arrangement in the hydrogen bonding network of 3 (view along the b axis). 
 
The ladder motif is also found in 2 (Fig. 6). Additionally to the NH...OP hydrogen bonds the second 
imidazolyl substituents forms NH...N hydrogen bridges to the imine N atom of the imidazolyl ring 
involved in the NH...OP system. This leads to the formation of a set of hydrogen bonds in the solid-
state best described by the graph set R66(37)R66(35) (Fig. 7). 
 
  
a) b)  
Fig. 6 Hydrogen bonding in the solid state of 2 (view along the b axis). (a) PO...HN chain along a 
axis and (b) NH...N chain along c axis. 
 
The situation in 1 is much more complicated due to the three imidazolyl substituents. Here a three-
dimensional hydrogen bonded network is found in which one molecule is hydrogen bonded to five 
others. The PO group forms hydrogen bonds to the nitrogen atoms of two imidazolyl groups N2 and 
N4 of different molecules of 1. The phosphorus atoms of four molecules can be placed on the 
corners of a distorted cube. Then, one each face a closed hydrogen-bonded pathway of four 
hydrogen bridges determines the network. The motif is described by the graph set 
R44(27)R44(23)R34(22) (Fig. 2). Interestingly, only hydrogen bridges between the atom pairs N4/O1, 
N6/O1 and N2/N5 describe these networks. 
In all three compounds only the imidazol-4-yl tautomer in the heteroaromatic substituents is found. 
Furthermore, the NH proton and the PO oxygen atom are located in a more or less transoid 
conformation, which contributes to the formation of the intermolecular NH...OP bonds in one 
direction. 
  
 
Fig. 7 Hydrogen bonding network in the solid state of 2. The two independent networks 
R66(37)R66(35) are shown. 
 
  
 
Fig. 8 Hydrogen bonding network in the solid state of 1. The three independent networks 
R44(27)R44(23)R34(22) are shown. 
  
Table 2 Crystal data and structure refinement for 1 - 3. 
 1 2 3 
Empirical formula  C18H27N6OP C18H23N4OP C18H19N2OP 
Formula weight  374.43 342.37 310.32 
Crystal system  Monoclinic Orthorhombic Orthorhombic 
Space group  Cc Pna21 Pca21 
a [Å]  19.5447(6)  11.5997(3)  10.8430(2)  
b [Å]  10.45764(16)  9.5836(2)  10.9277(2)  
c [Å]  10.8549(3)  16.1860(4)  27.7088(6)  
a [°]  90 90 90 
b [°]  121.418(4) 90 90 
g [°]  90 90 90 
Volume [Å3]  1893.36(8)  1799.35(7)  3283.19(11)  
Z 4 4 8 
Density (calculated) [Mg/m3]  1.314  1.264  1.256  
Absorption coefficient [mm-1]  0.166 0.165 0.171 
F(000) 800 728 1312 
Crystal size [mm3]  0.53 x 0.25 x 0.21  0.44 x 0.24 x 0.18  0.30 x 0.20 x 0.10  
Crystal description colourless plate colourless needle colourless plate 
Theta range for data collection 
[°]  
2.44 to 30.51 2.76 to 30.50 2.37 to 30.50 
Index ranges -27<=h<=27, -
14<=k<=14, -15<=l<=15 
-9<=h<=16, -12<=k<=13, 
-23<=l<=21 
-15<=h<=14, -
15<=k<=15, -29<=l<=39 
Reflections collected 14844 12583 25878 
Independent reflections 5418 [R(int) = 0.0229] 5284 [R(int) = 0.0245] 9065 [R(int) = 0.0375] 
Reflections observed 4983 4692 6701 
Criterion for observation >2sigma(I) >2sigma(I) >2sigma(I) 
Completeness to theta  100.0 % to 30.51°  99.9 % to 30.50°  100.0 % to 30.50°  
Max. and min. transmission 0.9660 and 0.9083 0.9709 and 0.9026 0.9831 and 0.8663 
Data / restraints / parameters 5418 / 2 / 259 5284 / 1 / 221 9065 / 1 / 401 
Goodness-of-fit on F2 1.035 0.983 0.941 
Final R indices [I>2sigma(I)] R1 = 0.0351, wR2 = 
0.0898 
R1 = 0.0336, wR2 = 
0.0782 
R1 = 0.0450, wR2 = 
0.0810 
R indices (all data) R1 = 0.0386, wR2 = 
0.0913 
R1 = 0.0384, wR2 = 
0.0797 
R1 = 0.0689, wR2 = 
0.0859 
Absolute structure parameter 0.16(6) -0.01(7) 0.00(6) 
Largest diff. peak and hole 
[e.Å-3]  
0.472 and -0.204 0.310 and -0.175 0.370 and -0.292 
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